Nucleic acids encoding interleukin-18 mutants

Details Nucleic acids encoding interleukin-18 mutants Nucleic acids encoding interleukin-18 mutants

2011-01-25

2011-01-25

Landsman, Robert (Department: 1646)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S069520, C424S085200

Reexamination Certificate

active

07875709

ABSTRACT:
The invention provides mutants of IL-18 with lower affinity to IL-18BP than the wild type IL-18 molecule.

REFERENCES:
patent: 9959565 (1999-11-01), None
Pecceu F, et al. Human interleukin 1 beta fused to the human growth hormone signal peptide is N-glcosylated and secreted by Chinese hamstere ovary cells. Gene, 1991, vol. 97(2), p. 253-258.
Dupre L et al. Immunostimulatory effect of IL-18-encoding plasmid DNA vaccination against murine Schistosoma mansoni infection. Vaccine, 2001, vol. 19(11-12), p. 1371-1380).
Anderson, D.M., et al. (1997) “A. homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.” Nature, 390, 175-179.
Bazan, J. F., et al. (1996) “A newly defined interleukin-1?” Nature 379, 591.
Born, T.L, et al. (2000) “A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.” J Immunol 164,3246-54.
Childs, R., et al. (2000) “Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.” N. Engl J Med 343, 750-8.
Cho, D., et al. (2000) “Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.” J Invest Dermatol,114, 928-34.
Coughlin, C.M., et al. (1998 ) “Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.” J Clin Invest Mar, 101,1441-52.
Engelmann, H., et al. (1989) “A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.” J. Biol. Chem. 264,11974-11980.
Engelmann, H., et al. (1990) “Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.” J. Biol. Chem. 265,1531-1536.
Ghayur, T., et al. (1997) “Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.” Nature 386, 619-623.
Gollob, J.A., et al. (2000) “Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.” Clin Cancer Res, 5, 1678-92.
Gong, J. H., et al. (1994) “Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.” Leukemia 8:652.
Gu, Y., et al. (1997) “Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme.” Science 275, 206-209.
Kim, S.H., et al. (2000) “Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.” Proc Natl Acad Sci U S A 97, 1190-5.
Kohno, K., et al. (1997) “IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL 12.” J. Immunol. 158:1541-1550.
Kugler, A., et al. (2000) “Regression of human metastatic renal cell-carcinoma after vaccination with tumor cell-dendritic cell hybrids.” Nat Med, 3, 332-6.
Nakamura, K., et al. (1989) “Endotoxin-induced serum factor that stimulates gamma interferon production.” InfectImmun 57,590-5 issn: 0019-9567.
Nakamura, K., et al. (1993) “Purification of a factor which provides a costimulatory signal for gamma interferon production.” Infect. Immun. 61, 64-70.
Novick, D., et al. (1989) “Soluble cytokine receptors are present in normal human urine.” J. Exp. Med. 170,1409-14.
Novick, D., et al. (1992) “Soluble Interferon-alpha Receptor Molecules Are Present in Body Fluids.” FEBS Lett 314, 445-8.
Novick, D., et al. (1994) “The Human Interferon alpha/beta Receptor—Characterization and Molecular Cloning.” Cell 77, 391-400.
Novick, D., et al. (1999) Interleukin-18 Binding Protein: A Novel Modulator of the Th1 Cytokine Response. Immunity 10, 127, 36.
Okamura, H., et al. (1995) “Cloning of a new cytokine that induces IFN-gamma production by T cells.” Nature 378, 88-91.
Puren, A.J., et al. (1999) “Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells.” Proc Natl Acad Sci USA, 96, 2256-61.
Seki, S., et al. (2000) “The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses.” Immunol Rev 174, 35-46.
Simonet, W.S., et al. (1997) “Osteoprotegerin: a novel secreted protein involved in the regulation of bone density”. Cell, 89, 309-19.
Slavin, S. (2000) “Immunotherapy of cancer with alloreactive lymphocytes.” N Engl J Med 343, 802-3.
Slavin, S., et al. (2000) “Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.” Bone Marrow Transplant Suppl 2:S54-7.
Tsutsui, H., et al. (1996) “IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.” J. Immunol. 157, 3967-73 issn: 0022-1767.
Tuting, T., et al. (1998) “Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.” J Immunol. 160, 1139-47.
Urushihara, N., et al. (2000) “Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia.” J Pediatr Surg 35, 446-9.
Ushio, S., et al. (1996) “Cloning of the cDNA for human IFN-gamma-inducing factor, expression inEscherichia coli, and studies on the biologic activities of the protein.” J. Immunol. 156, 4274-9.
Vigers, G.P., et al. (1997) “Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.” Nature 386,190-4.
Xiang, Y. and Moss, B. (1999) “IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.” Proc Natl Acad Sci U S A 96,11537-42.
Yasuda, H., et al. (1998) “Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogensis in vitro.” Endocrinology, 139, 1329-37.
Hesselgesser et al. (1997), Alanine scan mutagenesis of chemokines, Methods Enzymol 287:59-69.
Evans et al. (1995), Mapping Receptor Binding Sites in Interleukin {IL)-1 Receptor Antagonist and IL-1 Beta by Site-directed Mutagenesis, J Biol Chem 270(19):11477-11483.
Kim et al. (1999), Roles of IFN Consensus Sequence Binding Protein and PU.1 in Regulating IL-18 Gene Expression, J Immun 163:2000-2007.
Fu et al. (2001) “Asp(126), Asp(130) and Asp(134) are Necessary for Human IL-18 to Elicit IFN-gamma Production from PBMC” Acta Biochimica et Biophysica Sinica 33(4):368-372.
Stryer, L. Biochemistry, 3rd ed., 1988, p. 18-20.

Affiliated with

Also associated with

Rating

Nucleic acids encoding interleukin-18 mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acids encoding interleukin-18 mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding interleukin-18 mutants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2681982